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Actively caseating endobronchial tuberculosis successfully 
treated with intermittent chemotherapy without corticosteroid: 
a report of 2 cases
Abstract
Tuberculous infection of the tracheobronchial tree confirmed by microbiological or histopathological evidence with or without 
parenchymal involvement is known as endobronchial tuberculosis. Chronic cough is the predominant symptom. Expectorated 
sputum examination for acid fast bacilli is often negative leading to delay in diagnosis. Therefore, bronchoscopy is crucial for early 
diagnosis and evaluation of the extent of disease. Bronchostenosis is a significant complication of endobronchial tuberculosis 
that may be present at the time of diagnosis or develops during the course of treatment. Previously, corticosteroids have been 
used along with antitubercular therapy to prevent or reduce the extent of bronchostenosis; however, their role is debatable as 
bronchostenosis often develops despite the use of corticosteroids. Furthermore, the duration of treatment varied from 6–9 months 
of daily therapy in previous series and little is known about efficacy of intermittent antituberculous therapy. Here we report two 
cases of actively caseating endobronchial tuberculosis successfully managed with six months of intermittent oral antitubercular 
therapy without corticosteroids.
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Introduction
Endobronchial tuberculosis (EBTB) is cha-
racterized by tuberculous infection of the trache-
obronchial tree that is usually diagnosed by bron-
choscopy supplemented with a microbiological 
or histopathological confirmation. This can occur 
with or without parenchymal involvement [1, 2]. 
The reported incidence varied from 10–38.8% in 
earlier studies [3]. Recently EBTB was found in 
4.1% of unselected patients and in 54% of newly 
diagnosed pulmonary tuberculosis patients under-
going flexible bronchoscopy [3, 4]. In the absence 
of parenchymal disease or positive sputum micro-
biology, patients may be erroneously treated for 
other causes of chronic cough leading to potential 
delay in diagnosis and increased risk of transmis-
sion in the community [5–7]. There is no consen-
sus on the duration of antitubercular therapy or the 
use of corticosteroids in EBTB. Most studies have 
used daily antitubercular treatment for 6–9 months 
with or without corticosteroids [1–4]. The efficacy 
of intermittent therapy in EBTB is not known. We 
could find two studies reporting a total of 4 cases 
treated with intermittent antitubercular therapy 
along with corticosteroids [8, 9]. Here we report 
two cases of actively caseating EBTB successfully 
treated with 6-month intermittent oral antituber-
cular therapy without corticosteroids.
Case 1
A 24-year-old male presented in February 
2015 with breathlessness on exertion for 4 years, 
productive cough and feverishness lasting for 
two and half years. He had recurrent respirato-
ry symptoms since childhood but denied any 
treatment for tuberculosis. He never smoked to-
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Figure 1. Chest radiograph shows reduced right lung volume, hazi-
ness in the right paracardiac border, prominent pulmonary artery and 
hyperinflation of the left lung
Figure 2. CT scan in case 1 shows (A) agenesis of the right pulmonary artery with hyperinflation of the left lung and (B) right lung hypoplasia with 
infiltrates in the right middle and lower lobes (C, D) lung window in case 2 demonstrates bilateral infiltrates with lingular consolidation
bacco or drank alcohol. He worked in a plywood 
construction factory in the past four years. At 
presentation his vitals were as follows: pulse rate 
80/min, respiration rate 20/min, blood pressure 
110/60 mm Hg and oxygen saturation 98% in 
room air. Physical examination of the chest sho-
wed a shrunken right hemithorax with ipsilateral 
tracheal deviation. Auscultation revealed dimi-
nished vesicular breath sound with inspiratory 
crackles on a right side. Hemogram showed hemo-
globin concentration 14.5 gm%, white cell count 
4,900/cm with differentials of neutrophil 55%, 
lymphocytes 40%, eosinophil 3%, and monocytes 
2%. Blood metabolic panel, fasting blood glucose, 
liver function test and serum electrolytes were 
normal. Human immunodeficiency virus serology 
was negative. Chest radiograph showed reduced 
right lung volume, ipsilateral mediastinal shift, 
haziness in the right paracardiac area, prominent 
pulmonary artery and hyperinflation of the left 
lung (Fig. 1). Incidentally, contrast enhanced 
computed tomography (CT) scan demonstrated 
the main pulmonary artery continued as a single 
artery supplying the left lung and the right pulmo-
nary artery was absent (Fig. 2A). The right lung 
volume was reduced with nodular infiltrates in 
the middle and lower lobes and compensatory hy-
perinflation of the left lung was evident (Fig. 2B). 
Flexible bronchoscopy showed curd-white plaqu-
es covering the medial wall of the bronchus in-
termedius and middle and lower lobar openings 
with mucosal edema, hyperemia and luminal 
narrowing (Fig. 3A). Bronchial washing smear 
was positive for acid fast bacilli. Endobronchial 
biopsy showed granuloma with caseous necrosis 
and the presence of acid fast bacilli (Fig. 4A, C). 
Subsequently, expectorated sputum examination 
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Figure 3. Bronchoscopy in case 1 showed (A) curd-white caseous material diffusely involving the bronchus intermedius, right middle and lower 
lobes bronchi (B) complete resolution after treatment with significant narrowing of lower lobe bronchus and stenosed middle lobe bronchus (arrow). 
Bronchoscopy in case 2 showed (C) whitish caseous tissue covering the left upper lobe bronchial surface (D). Complete resolution of pathology 
after treatment without bronchostenosis
Figure 4. Endobronchial biopsy showing (A) granulomas and caseous necrosis in case 1 (H&E, 40 ×), (B) caseating epithelioid granuloma in case 
2 (H&E, 400 ×), (C, D) Ziehl-Neelsen stain demonstrates acid fast bacilli in both patients (Z&N, 1000 ×)
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Table 1. Clinical characteristics of patients with endobronchial tuberculosis
Patient 
number
Age 
(years) 
Sex Symptoms Sputum for 
AFB
CXR  
findings
CT scan
findings 
EBTB 
type
Site of 
EBTB
Treatment Outcome 
Case 1 24 Male Cough Positive Right pa-
racardiac 
haziness
Nodular infil-
trates in RML 
and RLL
Caseating Right  
bronchial 
tree
Six months 
intermittent 
ATT 
Bronchoste-
nosis RML 
bronchus
Case 2 57 Male Cough Negative Infiltartes 
in LUL
b/l infiltartes, 
tree-in-bud 
pattern,  
lingular  
consolidation
Case-
ating 
Left up-
per lobe
Six months 
intermittent 
ATT
Complete 
healing No 
bronchoste-
nosis
AFB — acid fast bacilli; CXR — Chest X-ray; CT — computed tomography; EBTB — endobronchial tuberculosis; RML — right middle lobe; RLL — right lower lobe;
ATT — antitubercular therapy; LUL — left upper lobe
also demonstrated acid fast bacilli. Echocardio-
graphy revealed a hypoplastic main pulmonary 
artery, invisible right pulmonary artery, mild 
pulmonary artery hypertension and normal left 
ventricular systolic function. Right pulmonary 
artery agenesis with actively caseating endobron-
chial tuberculosis was diagnosed and treated 
with thrice weekly regimen consisting of isonia-
zid 600 mg, Rifampicin 450 mg, Pyrazinamide 
1,500 mg and Ethambutol 1,200 mg for initial 2 
months followed by Isoniazid and Rifampicin in 
the next 4 months. The patient improved symp-
tomatically and a  repeated bronchoscopy after 
treatment completion showed resolution of the 
endobronchial lesion with significant narrowing 
of the lower lobe bronchus and stenosis of the 
middle lobe bronchus (Fig. 3B). The patient was 
doing well at last contact six months after com-
pletion of treatment.
Case 2
A 57-year-old male presented in November 
2015 with cough and decreased appetite for 2 
months. Cough was persistent despite taking 
several courses of antibiotics and cough sup-
pressants. He had no other pulmonary or extra-
pulmonary symptoms. He worked in an office, 
was a never smoker and had no comorbid ill-
ness. Physical examination was unremarkable. 
Chest auscultation revealed bilateral normal 
breath sound with scant crackles on the left 
mammary area. Hemogram, liver and kidney 
functions were within normal limits. Human 
immunodeficiency virus serology was negative. 
Two consecutive sputum smears for acid fast 
bacilli were negative. Chest radiograph showed 
alveolar infiltrates in the left upper lobe sug-
gesting tuberculosis. High resolution CT scan 
demonstrated patchy bilateral infiltrates in the 
lungs with tree-in-bud pattern and lingular con-
solidation (Fig. 2C, 2D). Flexible bronchoscopy 
showed mild narrowing of the left main and 
upper lobe bronchi with cheesy-white material 
covering the left upper lobe bronchial divisions 
(Fig. 3C). Bronchial washing smear was positive 
for acid fast bacilli and endobronchial biopsy 
demonstrated caseating epithelioid granuloma 
and clumps of acid fast bacilli confirming ca-
seous endobronchial tuberculosis [Fig. 4B 4D). 
The patient received intermittent antituber-
cular therapy for 6 months similarly to case 1 
(Table 1). He improved clinically and repeated 
bronchoscopy at the end of therapy showed 
complete resolution of the lesion without any 
significant bronchial stenosis (Fig. 3D). 
Discussion
EBTB is a special form of tuberculosis mostly 
affecting people in their second or third decade 
with an incidence 3-5 times more common in fe-
males than males. The right bronchial tree is most 
commonly involved. Unrelenting cough with or 
without fever is the predominant symptom [1–4]. 
Sometimes patients may present with wheeze due 
to endobronchial obstruction or bronchostenosis 
mimicking asthma [5], foreign body aspiration [6], 
and malignancy [7]. Thus, a clinical diagnosis 
is very difficult, and bronchoscopy is crucial in 
early diagnosis of EBTB. 
Bronchoscopically, EBTB is classified into 
seven types, namely actively caseating, ede-
matous-hyperemic, fibrostenotic, tumorous, 
granular, ulcerative, and nonspecific bronchitic 
[10]. Actively caseating lesions are those where 
the bronchial mucosa is swollen, hyperemic, 
and diffusely covered with whitish cheese-like 
material. This form is usually associated with 
luminal narrowing at diagnosis irrespective of 
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the presence or absence of granulation tissue. 
In the edematous-hyperemic type, the bronchial 
lumen is almost always narrowed due to severe 
mucosal swelling with surrounding hyperemia. 
The tumorous type presents as endobronchial 
mass mimicking lung cancer. Granular variety 
appears like scattered grains of boiled rice on 
bronchial surface, whereas mucosal ulcerations 
may be seen in the ulcerative type. Nonspecific 
bronchitic form is characterized by mild mucosal 
swelling and/or hyperemia. Different forms of 
EBTB may be present concomitantly in a single 
patient and one form may transform to another 
during the course of treatment before final healing 
or progression to bronchostenosis. Edematous 
hyperemic and active caseating types have the 
highest propensity for progression to fibroste-
notic variety, whereas ulcerative and nonspecific 
bronchitic types are the milder forms with excel-
lent prognosis where complete healing usually 
occurs in 2-3 months of treatment. Tumorous 
EBTB has a highly unpredictable course with 
worst possible prognosis where new tumorous 
lesions may appear even after adequate duration 
or completion of treatment, and often leads to 
complete luminal obstruction [10]. Female sex, 
duration of symptoms longer than four weeks 
and no past history of tuberculosis are reported 
as independent predictors of concomitant EBTB 
in patients with active pulmonary tuberculosis. 
About one-fifth of patients end up having signi-
ficant bronchostenosis with luminal narrowing 
experienced by more than one-third. The initial 
length of airway involvement and low forced 
expiratory volume in one second are risk factors 
for persistent bronchostenosis [4].
The pathogenesis is yet to be understood 
completely. The proposed mechanisms of en-
dobronchial involvement are direct extension 
from adjacent parenchymal focus, implantation 
of organisms from the infected sputum, hemato-
genous dissemination, lymph node erosion into 
the bronchus, and through lymphatic drainage 
from parenchyma to the peribronchial region 
[11]. Chest radiographs may be normal or show 
parenchymal infiltrates, atelectasis, and obstructi-
ve hyperinflation. CT scan is helpful in assessing 
the length of stenotic segment, peribronchial 
thickness, luminal patency and response to tre-
atment [3].
Surprisingly, expectorated sputum smear po-
sitivity rate is low in EBTB [1–4]. Bronchoscopy is 
helpful in early diagnosis as well as in predicting 
the course of disease [1, 10]. Histopathology of 
endobronchial biopsy is essential for diagnosis as 
bronchial lavage microbiology may be negative. 
The diagnostic yield is higher with combination 
of different bronchoscopic samplings [1, 8].
The treatment is similar to pulmonary tuber-
culosis with standard antitubercular drugs. Most 
patients respond to this regimen with a residual 
sequel of airway stenosis in about one-fifth of 
them. Corticosteroids are often used with intent 
to prevent or reduce bronchostenosis. However, 
bronchostenosis seems to be inevitable despite 
treatment [1–4]. The role of corticosteroids in 
EBTB remains controversial. Two randomized 
trials in children conducted in the 1960s, when 
effective antitubercular drugs were not available, 
showed favorable response in the steroid groups 
[12, 13], whereas the only trial conducted in 
adult patients failed to demonstrate any benefits 
of steroids [14]. Another study found that age > 
45 years, fibrostenotic subtype and > 90 days 
between onset of symptom to the initiation of 
antituberculosis chemotherapy were independent 
predictors of persistent airway stenosis, and oral 
corticosteroids did not reduce the frequency of 
airway stenosis [15]. In view of this conflicting 
evidence, we did not use steroids in our patients. 
Furthermore, our patients received thrice weekly 
regimen under the revised national tuberculosis 
control program in contrast to other studies where 
daily therapy was used. In a previous series, six 
months of daily antitubercular therapy witho-
ut corticosteroid was shown to be effective in 
managing tumorous EBTB in four patients [16]. 
The successful use of intermittent chemotherapy 
along with steroids has been reported in four 
patients with EBTB [8, 9]. We found remarkable 
improvement in both patients after 6 months of 
antitubercular therapy without steroids; however, 
significant residual bronchial narrowing was no-
ted in the first case. Because this patient also had 
right pulmonary artery agenesis with hypoplastic 
right lung, it is difficult to ascertain whether 
bronchial narrowing is purely a consequence of 
disease or partly developmental due to lung hy-
poplasia. The long duration of symptoms in this 
patient prior to treatment might have aggravated 
the airway narrowing as well. 
In conclusion, a high index of suspicion is 
required for early detection of EBTB. Bronchosco-
py is essential for the diagnosis and assessment 
of treatment response. Short course intermittent 
chemotherapy of 6 months without steroids may 
be adequate for successful management of case-
ating endobronchial tuberculosis.
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